- Global Pharma News & Resources

Artificial Intelligence in Medicine Market Expected to Reach $18 Bn – Industry Analysis by Top Key Players, Latest Trends, Regional Insights and Global Industry Dynamics By 2025

Pune, Maharashtra, India, September 8 2020 (Wiredrelease) Allied Analytics –:According to the report by Allied Market Research, the Artificial Intelligence in Medicine Market is estimated to reach $18,119 million at a CAGR of 49.6% by 2025. Porter’s Five Forces Analysis is mentioned in the report to offer insights on competitive intensity and devise expansion strategies for market players. In addition, key player positioning and the future scenario are mentioned in the research. Driving factors and opportunities in various regions would be helpful in determining strategies for expansion. Market size and estimations are presented in tabular and graphical formats for better understanding for users and gain valuable information for taking further steps. Competitive landscape is discussed for leading market players. 

Increase in processing power of AI systems for enhanced AI capabilities, dearth of skilled healthcare professionals, and increase in applications of innovative screening methods would facilitate the growth of the artificial intelligence in healthcare market

Download Sample PDF of Report with COVID-19 Impact Analysis@

In the field of medicine, artificial intelligence (AI) can be used for research studies and applications that support decision-based medical tasks using data-intensive computer-based solutions. For every drug that is launched in the market, the pharmaceutical industry spends on an average $2.7 billion, which amortizes the losses incurred from the aborted pipelines. Almost 90% of all drug programs that reach clinical trial stages are aborted. Thus, many large pharma and academic research institutions are focusing on use of AI to increase efficiencies and design better drugs.

Major Key Companies in Market:-

The key players operating in the global artificial intelligence in medicine market include Welltok, Inc., Intel Corporation, Nvidia Corporation, Google Inc., IBM Corporation, Microsoft Corporation, General Vision, Inc., Enlitic, Inc., BioXcel Corporation, and Berg Health.

Other prominent players in the value chain include InSilico Medicine, Inc., Globavir Biosciences, Inc., GNS Healthcare, Flatiron Health, Benevolent AI, Atomwise, Verge Genomics, Cloud Pharmaceuticals, and Recursion Pharmaceuticals.

The major factors that drive the growth of the AI in medicine market include shortage of skilled healthcare professionals, the growth in importance of precision medicine, and increase in the processing power of AI systems that is estimated to help improve the efficiency of drug discovery and management of clinical trials. However, limited acceptance from healthcare professionals and limitations of AI decision-making limit the market growth. Conversely, the untapped market potential in developing regions such as India and China is anticipated to provide numerous opportunities for the market growth during the forecast period.

Among the technology segments, the natural language processing segment accounted for the highest share in 2017 and is expected to dominate the market from 2017 to 2023. The deep learning segment is projected to grow at the highest CAGR during the forecast period, owing to increase in use of signal reduction, data mining, and image recognition, which are integral components of most AI protocols.


Among the product type, the software segment occupied the highest share in 2017, owing to continuous software innovation that caters to the requirement in the healthcare sector. The hardware segment is projected to witness the highest growth rate during the forecast period.

For Purchase Enquiry@

Key Findings of the Artificial Intelligence in Medicine Market:-

The personalized medicine segment is projected to grow at the highest rate among the application segment during the analysis period. North America dominated global artificial intelligence in medicine market in 2017 and is projected to continue its dominance in future. China is expected to grow at the highest rate in Asia-Pacific during the forecast period. Software is the largest contributor among the product type segments in 2017. The natural language processing segment generated the highest revenue and is expected to continue its dominance in future.

Based on region, North America occupied the largest share in 2017 owing to availability of capital investments for use of AI in drug discovery and increase in adoption of AI technology by the pharmaceutical and biotechnology companies. However, Asia-Pacific is expected to grow at the highest CAGR of 55.0% during the study period, due to growth in healthcare expenditure, rise in the R&D activities for advancement in AI technology, lack of healthcare professionals, and increase in need to reduce the healthcare costs.

Similar Report with COVID-19 Impact Analysis:-

Remote Patient Monitoring Market – Global Opportunity Analysis and Industry Forecast, 2019–2026

Asia-Pacific Oncology Molecular Diagnostics Market – Opportunity Analysis and Industry Forecast, 2019–2026

Pediatric Ultrasound Market – Global Opportunity Analysis and Industry Forecast, 2019–2026

Neuroprosthetics Market – Global Opportunity Analysis and Industry Forecast, 2019–2026

Male Hypogonadism Market – Global Opportunity Analysis and Industry Forecast, 2019–2026

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 08-Sep-2020